These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 1361533)
1. Effect of uraemia and anephric state on the pharmacokinetics of tenoxicam in the rat. Lopez-Bustamante LG; Troconiz JI; Fos D J Pharm Pharmacol; 1992 Nov; 44(11):898-901. PubMed ID: 1361533 [TBL] [Abstract][Full Text] [Related]
2. Tenoxicam pharmacokinetics in rats: a population model. Troconiz IF; Lopez-Bustamante LG; Fos D J Pharm Sci; 1995 Dec; 84(12):1482-7. PubMed ID: 8748332 [TBL] [Abstract][Full Text] [Related]
4. Single- and multiple-dose pharmacokinetics, kidney tolerability and plasma protein binding of tenoxicam in renally impaired patients and healthy volunteers. Nilsen OG; Aasarød K; Widerøe TE; Guentert TW Pharmacol Toxicol; 2001 Nov; 89(5):265-72. PubMed ID: 11881981 [TBL] [Abstract][Full Text] [Related]
5. Effect of induced hypoalbuminemia on distribution, total clearance and unbound clearance of piroxicam in vivo in the rat. Troconiz JI; Lopez-Bustamante LG; Fos D Eur J Drug Metab Pharmacokinet; 1993; 18(2):165-71. PubMed ID: 8243500 [TBL] [Abstract][Full Text] [Related]
6. Indirect assessment of the enterohepatic recirculation of piroxicam and tenoxicam. Benveniste C; Striberni R; Dayer P Eur J Clin Pharmacol; 1990; 38(6):547-9. PubMed ID: 2373127 [TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of total and unbound concentrations of tenoxicam in synovial fluid and plasma. Day RO; Williams KM; Graham S; Handel M Arthritis Rheum; 1991 Jun; 34(6):751-60. PubMed ID: 2053921 [TBL] [Abstract][Full Text] [Related]
9. The effect of haemodialysis on the pharmacokinetics of tenoxicam in patients with end-stage renal disease. al-Ghamdi MS; al-Mohanna FA; al-Mustafa ZH; al-Saeed IS Eur J Clin Pharmacol; 1992; 43(2):197-9. PubMed ID: 1425878 [TBL] [Abstract][Full Text] [Related]
10. The influence of cholestyramine on the elimination of tenoxicam and piroxicam. Guentert TW; Defoin R; Mosberg H Eur J Clin Pharmacol; 1988; 34(3):283-9. PubMed ID: 3260866 [TBL] [Abstract][Full Text] [Related]
11. Effect of uremia and anephric state on the pharmacokinetics of sulindac and its metabolites in rats. I. An application of pharmacokinetic model for reversible metabolism. Lin JH; Yeh KC; Duggan DE Drug Metab Dispos; 1985; 13(5):602-7. PubMed ID: 2865111 [TBL] [Abstract][Full Text] [Related]
12. Integrated plasma and synovial fluid pharmacokinetics of tenoxicam in patients with rheumatoid arthritis and osteoarthritis: factors determining the synovial fluid/plasma distribution ratio. Hinderling PH; Hartmann D; Crevoisier C; Moser U; Heizmann P Ther Drug Monit; 1988; 10(3):250-60. PubMed ID: 3262939 [TBL] [Abstract][Full Text] [Related]
13. Intranasal delivery of tenoxicam in rat. Raghavan CV; Abimon VD Int J Pharm; 2001 Jun; 221(1-2):227-9. PubMed ID: 11397584 [TBL] [Abstract][Full Text] [Related]
14. Single and multiple dose pharmacokinetics of tenoxicam in the elderly. Nilsen OG; Walstad RA; Eckert M; Heizmann P; Bückert A; Am T; Løge I; Unnvik J; Thue E Eur J Clin Pharmacol; 1988; 35(5):563-6. PubMed ID: 3266152 [TBL] [Abstract][Full Text] [Related]
15. Plasma tenoxicam concentrations after single and multiple oral doses. Crevoisier C; Heizmann P; Forgo I; Dubach UC Eur J Drug Metab Pharmacokinet; 1989; 14(1):23-7. PubMed ID: 2788089 [TBL] [Abstract][Full Text] [Related]
16. Overview on the pharmacokinetics of tenoxicam. Guentert TW; Heintz RC; Joly R Eur J Rheumatol Inflamm; 1987; 9(2):15-25. PubMed ID: 3329107 [TBL] [Abstract][Full Text] [Related]
17. High-performance liquid chromatographic analysis of piroxicam and tenoxicam in plasma, blood and buffer solution. Application to pharmacokinetic studies in small laboratory animals. Troconiz JI; Lopez-Bustamante LG; Fos D Arzneimittelforschung; 1993 Jun; 43(6):679-81. PubMed ID: 8352822 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of formulated tenoxicam transdermal delivery systems. Kim T; Kang E; Chun I; Gwak H J Pharm Pharmacol; 2008 Jan; 60(1):135-8. PubMed ID: 18088513 [TBL] [Abstract][Full Text] [Related]